Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026)
Sol-Gel Technologies' Cash & Current Investments was $47.93 million in Q2 2026, up 97.4% from $24.28 million a year earlier but down 9.3% from the prior quarter.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Cash & Current Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Sol-Gel Technologies came in at $24 million, up 0.4% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $23.91 million in FY2024 (-14.5%), $27.98 million in FY2023 (+32.5%), $21.13 million in FY2022 (-3.1%) and $21.79 million in FY2021 (-24.3%).
- Quarterly Cash & Current Investments has moved between $15.61 million (Q2 2022) and $52.83 million (Q1 2026) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 26.5% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2026 (growth of 212.8%); the worst was Q3 2022 (a decline of 59.9%).
- Per Business Quant data, SLGL's Cash & Current Investments in the three quarters before Q2 2026 was $52.83 million (Q1 2026), $24 million (Q4 2025) and $20.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Sol-Gel Technologies | 172.72 Mn | 27.14 Mn | - | 47.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.93 Mn |
| Mar 31, 2026 | 52.83 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 20.83 Mn |
| Jun 30, 2025 | 24.28 Mn |
| Mar 31, 2025 | 16.89 Mn |
| Dec 31, 2024 | 23.91 Mn |
| Sep 30, 2024 | 28.05 Mn |
| Jun 30, 2024 | 26.46 Mn |
| Mar 31, 2024 | 28.01 Mn |
| Dec 31, 2023 | 27.98 Mn |
| Sep 30, 2023 | 31.32 Mn |
| Jun 30, 2023 | 33.48 Mn |
| Mar 31, 2023 | 25.25 Mn |
| Dec 31, 2022 | 21.13 Mn |
| Sep 30, 2022 | 18.30 Mn |
| Jun 30, 2022 | 15.61 Mn |
| Mar 31, 2022 | 27.31 Mn |
| Dec 31, 2021 | 21.79 Mn |
| Sep 30, 2021 | 45.59 Mn |
API Access
Sol-Gel Technologies Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SLGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();